Daridorexant is a dual orexin receptor antagonist used in the treatment of insomnia by blocking orexin signaling to reduce wakefulness. This category provides essential reference standards for the active… Read more






Daridorexant is a dual orexin receptor antagonist used in the treatment of insomnia by blocking orexin signaling to reduce wakefulness. This category provides essential reference standards for the active pharmaceutical ingredient, alongside its related synthetic impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories require these materials for comprehensive analytical testing, including impurity profiling, method development, and regulatory quality control. The inclusion of stable isotope-labelled versions provides necessary internal standards for accurate quantitative analysis in mass spectrometry-based assays. By utilizing these well-characterized reference materials, researchers can effectively monitor degradation products and ensure the accuracy of analytical methods throughout the production and evaluation of this therapeutic agent.